Nova Leap Health Corp. (NVLPF)
USD 0.18
(3.2%)
USD 0.18
(3.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 914.05 Thousand USD | -28.49% |
| 2022 | 1.27 Million USD | -33.46% |
| 2021 | 1.92 Million USD | -37.57% |
| 2020 | 3.07 Million USD | 46.09% |
| 2019 | 2.1 Million USD | 273.81% |
| 2018 | 563.48 Thousand USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 178.28 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 24.06 Thousand USD | 0.0% |
| 2024 Q1 | 846.51 Thousand USD | 0.0% |
| 2023 FY | 914.05 Thousand USD | -28.49% |
| 2023 Q2 | 1.14 Million USD | -5.34% |
| 2023 Q4 | 914.05 Thousand USD | -13.98% |
| 2023 Q1 | 1.21 Million USD | -4.98% |
| 2023 Q3 | 1.06 Million USD | -7.57% |
| 2022 Q3 | 1.71 Million USD | -9.1% |
| 2022 FY | 1.27 Million USD | -33.46% |
| 2022 Q1 | 1.87 Million USD | -2.28% |
| 2022 Q2 | 1.88 Million USD | 0.47% |
| 2022 Q4 | 1.27 Million USD | -25.45% |
| 2021 Q3 | 1.19 Million USD | 5.61% |
| 2021 Q4 | 1.92 Million USD | 60.73% |
| 2021 FY | 1.92 Million USD | -37.57% |
| 2021 Q1 | 1.49 Million USD | -51.49% |
| 2021 Q2 | 1.13 Million USD | -24.19% |
| 2020 FY | 3.07 Million USD | 46.09% |
| 2020 Q4 | 3.07 Million USD | 24.16% |
| 2020 Q3 | 2.47 Million USD | 2.58% |
| 2020 Q2 | 2.41 Million USD | 2.39% |
| 2020 Q1 | 2.35 Million USD | 12.02% |
| 2019 Q4 | 2.1 Million USD | 342.26% |
| 2019 FY | 2.1 Million USD | 273.81% |
| 2019 Q1 | 460.93 Thousand USD | -18.2% |
| 2019 Q2 | 542.4 Thousand USD | 17.67% |
| 2019 Q3 | 476.28 Thousand USD | -12.19% |
| 2018 Q4 | 563.48 Thousand USD | 13.59% |
| 2018 FY | 563.48 Thousand USD | 0.0% |
| 2018 Q1 | 134 Thousand USD | 0.0% |
| 2018 Q2 | 351.61 Thousand USD | 162.4% |
| 2018 Q3 | 496.07 Thousand USD | 41.08% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 FY | - USD | -100.0% |
| 2017 Q1 | 142.48 Thousand USD | 0.0% |
| 2016 Q3 | 178.39 Thousand USD | 0.0% |
| 2016 FY | 178.28 Thousand USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | 1.82 Million USD | 49.955% |
| Arem Pacific Corporation | 151.51 Thousand USD | -503.286% |
| Assisted 4 Living, Inc. | - USD | -Infinity% |
| BioCorRx Inc. | 3.89 Million USD | 76.534% |
| Bionik Laboratories Corp. | 2.39 Million USD | 61.759% |
| Banyan Corp. | 2.43 Million USD | 62.407% |
| Clearday, Inc. | 25.8 Million USD | 96.458% |
| Dental Patient Care America, Inc. | - USD | -Infinity% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | 1.93 Million USD | 52.66% |
| First Choice Healthcare Solutions, Inc. | 1.28 Million USD | 28.791% |
| Selectis Health, Inc. | 25.17 Million USD | 96.369% |
| Ethema Health Corporation | 20.52 Thousand USD | -4354.464% |
| HealthLynked Corp. | 450 Thousand USD | -103.124% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | - USD | -Infinity% |
| JRSIS Health Care Corporation | 24.95 Thousand USD | -3563.551% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 54.46 Million USD | 98.322% |
| MedSmart Group Inc. | 50 Thousand USD | -1728.112% |
| North America Frac Sand, Inc. | - USD | -Infinity% |
| Nexteligent Holdings, Inc. | - USD | -Infinity% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 6.89 Million USD | 86.743% |
| Raffles Medical Group Ltd | 52.43 Million USD | 98.257% |
| Ryman Healthcare Limited | 1.52 Billion USD | 99.94% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 57.07 Thousand USD | -1501.388% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | 58 Thousand USD | -1475.959% |
| Veltex Corporation | - USD | -Infinity% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | - USD | -Infinity% |